Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane

First Page		Document Content
Date: 2015-08-29 15:36:41 Ion channels Electrophysiology Biology Integral membrane proteins Physiology Neuroscience Carbamates Retigabine Potassium channel Voltage-gated potassium channel		Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane Add to Reading List Source URL: theplesslab.com Download Document from Source Website File Size: 531,25 KB Share Document on Facebook

	Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane DocID: 1qUxQ - View Document
	REVIEWS PHYSIOLOGY 19: 293–299, 2004; physiolA Two-Holed Story: Structural Secrets About ClC Proteins Become Unraveled? DocID: 1oNGO - View Document
	FEBS Letters–4001 journal homepage: www.FEBSLetters.org A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3 DocID: 1mP4v - View Document
	Principles of conduction and hydrophobic gating in Kþ channels Morten Ø. Jensena, David W. Borhania, Kresten Lindorff-Larsena, Paul Maragakisa, Vishwanath Joginia, Michael P. Eastwooda, Ron O. Drora, and David E. Shawa DocID: 1mgfa - View Document
	59 J Physiolpp 59–74 Protein kinase C shifts the voltage dependence of KCNQ/M channels expressed in Xenopus oocytes DocID: 132dC - View Document